The impact of a pharmacist-led Comprehensive Diabetes Management Program in a Federally Qualified Health Center
Journal of the American Pharmacists Association · 2025
DOI: 10.1016/j.japh.2025.102399 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Pharmacists Association, 2025. Verfasst von Charmaine D Rochester-Eyeguokan und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: Pharmacists, Diabetes Mellitus. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Maryland Department of Health.
Themen: Diabetes mellitus
Abstract (Originalsprache)
BACKGROUND: Diabetes mellitus is a prevalent chronic disease associated with significant complications and economic burdens. A substantial portion of the population in the United States has diabetes, with considerable variability in achieving treatment targets. Yearly estimates of the national burden reach billions of dollars. In response to a request from a Federally Qualified Health Center, the Center for Innovative Pharmacy Solutions at the University of Maryland School of Pharmacy developed a Comprehensive Diabetes Management Program (CDMP). Clinical pharmacists and a licensed dietitian provided direct patient-care services to address high A1C levels, limited health care access, and health literacy. Patients were eligible for the CDMP if the most recent hemoglobin A1c was >7%. The program involved comprehensive patient evaluation, treatment optimization, educational initiatives, and interdisciplinary collaboration. OBJECTIVE: This study aimed to assess the impact of pharmacist-led interventions on clinical and economic outcomes within the CDMP. METHODS: This retrospective, 2-year prepost analysis study includes clinical and economic analyses of patients enrolled between August 1, 2021, and August 31, 2023. Patients were included if they attended more than one pharmacy visit with an available postintervention A1c. The primary clinical outcome was the change in A1c level from baseline to follow-up analyzed using a paired t test and McNemar's test for categorical changes. Costs were analyzed using hospitalizations and utilization data retrieved from the regional health information exchange. A segmented regression of interrupted time series was conducted to evaluate cost trends, and the return on investment was calculated. RESULTS: The study enrolled 518 patients, revealing a statistically significant mean reduction in A1c levels, alongside observed cost savings in health care utilization due to reduced hospitalizations. CONCLUSION: This study underscores the considerable advantages of integrating pharmacists into diabetes management programs, particularly for patients with elevated A1c levels >9%.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Förderung
- Maryland Department of Health
Zitieren
APA
Rochester-Eyeguokan, C. D., Pincus, K. J., Sokan, O. M., & Seung, H. (2025). The impact of a pharmacist-led Comprehensive Diabetes Management Program in a Federally Qualified Health Center. Journal of the American Pharmacists Association. https://doi.org/10.1016/j.japh.2025.102399
Vancouver
Rochester-Eyeguokan CD, Pincus KJ, Sokan OM, Seung H. The impact of a pharmacist-led Comprehensive Diabetes Management Program in a Federally Qualified Health Center. Journal of the American Pharmacists Association. 2025. doi:10.1016/j.japh.2025.102399
BibTeX
@article{RochesterEyeguokan2025,
author = {Rochester-Eyeguokan, Charmaine D and Pincus, Kathleen J and Sokan, Olufunke M and Seung, Hyunuk},
title = {The impact of a pharmacist-led Comprehensive Diabetes Management Program in a Federally Qualified Health Center},
journal = {Journal of the American Pharmacists Association},
year = {2025},
doi = {10.1016/j.japh.2025.102399}
}
EUVIMED